Jan 9 (Reuters) - Aralez Pharmaceuticals Inc ARZ.TO
* Aralez provides update on PBM formulary status for Yosprala
* Entered into a rebate agreement with Express Scripts Inc., which secures formulary status for Yosprala
* Rebate agreement with Express Scripts became effective January 1, 2017 Source text for Eikon: ID:nCNWbKFvha Further company coverage: ARZ.TO